Drugs / Colostrum
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06857318 | May → Aug 2023 | COVID-19 | Hadassah Medical Organization | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00747071 | Sep 2011 → Nov 2012 | Clostridium difficile colitis | Hadassah Medical Organization | Withdrawn | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03578341 | Jun 2018 → Oct 2019 | immunodeficiency disease | Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06869902 | Sep 2023 → Jun 2024 | ankyloglossia | Parc de Salut Mar | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT06549556 Comparator | Aug → Dec 2024 | type 2 diabetes mellitus | Al-Rasheed University College | Completed | No outcome recorded |
| Phase 2 | NCT06007430 Comparator | Mar → Oct 2023 | type 2 diabetes mellitus | Al-Mustafa University College | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colostrum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06549556 ↗ |
| Known as | Colostrum 500 mg Veg Capsules | “Brand name: (Colostrum® 500 mg Veg Capsules) capsules per oral / once daily / 60 days duration.” NCT06549556 ↗ |
| Modality | Protein / enzyme biologic | “Colostrum derived antibodies” NCT00747071 ↗ |
| Route | Oral | “Oral administration” NCT00747071 ↗ |